Skip to main content

NEULANDLAB · Neuland Laboratories Limited · Financials

21,078.00 INR +155.00 (+0.74%) At close · Nov 13
Market Cap
270.43B INR
Shares
12.83M
Volume · Nov 13 70.76K Avg daily vol (3M) 50.13K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
20.23B +37%
FY2026 Revenue FY2020–FY2026
Net Income
3.64B
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
3.47B +9.2%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 23.07B 20.23B 14.77B 15.59B 11.91B 9.51B 9.37B 7.63B
INR 1.04B 917.4M 655.47M 597M 527.77M 490.4M 396.83M 312.8M
INR 282.75M 239.47M 82.97M 139.97M 130.67M 134.95M 178.98M 215.74M
INR 6.09B 4.89B 3.46B 4.01B 2.16B 821.63M 1.05B 529.23M
INR 1.56B 1.25B 862.21M 1.01B 522.29M 183.41M 247.03M 367.12M
INR 4.53B 3.64B 0 0 1.64B 638.22M 806.31M 162.11M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 564.52M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.